Prot# DR-OXY-301: A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of Two Doses of DR-3001 versus Placebo in Women with Overactive Bladder

Project: Research project

Project Details

StatusFinished
Effective start/end date8/14/088/14/11

Funding

  • Duramed Pharmaceuticals, Inc. (DR-OXY-301)